Both in Pharmaceuticals
Zenas BioPharma vs Nurix Therapeutics
Over the past year ZBIO returned −9.0% and NRIX returned +26.1%; their daily moves had a correlation of 0.18.
ZBIO −9.0% NRIX +26.1%Growth of $1, one year, split-adjusted
| Metric | ZBIO | NRIX |
|---|---|---|
| Price | $28.51 | $15.92 |
| Market cap | $1.86B | $1.74B |
| Today | +0.44% | −38.34% |
| 1 month | +5.8% | −29.6% |
| 6 months | +36.8% | −5.7% |
| Year to date | −21.5% | −16.1% |
| 1 year | −9.0% | +26.1% |
| Revenue growth (YoY) | — | +8426.3% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −11145.6% | 81.7% |
| P/E (TTM) | — | 5.9× |
| Price / sales | 1,857.9× | 2.5× |
| Net cash | $346.1M | $1.05B |
| Dividend yield | — | — |
| Volatility (60d) | 55.9% | 105.0% |
| Short % of float | 40.2% | 21.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).